Development and validation of an HPLC-UV method for the quantification of carbamazepine in rabbit plasma

Saudi Pharmaceutical Journal

Volumn 20, Issue 1, 2012, Pages 29-34

  Mowafy, Hammam A ^a,d   Alanazi, Fars K ^a,b   El Maghraby, Gamal M ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c TANTA UNIVERSITY   (Egypt)

^d Cairo University   (Egypt)

Author keywords

Carbamazepine; HPLC method; Rabbit plasma; Validation

Indexed keywords

CARBAMAZEPINE; PROPYL PARABEN;

ACCURACY; ANIMAL TISSUE; ARTICLE; CALIBRATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; EXPERIMENTAL RABBIT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NONHUMAN; ULTRAVIOLET RADIATION; VALIDATION STUDY;

EID: 83355166867     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2011.04.003     Document Type: Article

References (38)

1. Ashy A.R., El Sayed Y.M., Islam S.I. Comparison of fluorescence polarization immunoassay and high performance liquid chromatography for the quantitative determination of phenytoin, phenobarbitone and carbamazepine in serum. J. Pharm. Pharmacol. 1986, 38:572-577.
2. Auer M.E., Griesser U.J., Sawatzki J. Qualitative and quantitative study of polymorphic forms in drug formulations by near infrared FT-Raman spectroscopy. J. Mol. Struct. 2003, 661-662(1-3):307-317.
3. Bhatti M.M., Hanson G.D., Schultz L. Simultaneous determination of phenytoin, carbamazepine, and 10,11-carbamazepine epoxide in human plasma by high-performance liquid chromatography with ultraviolet detection. J. Pharm. Biomed. Anal. 1998, 16:1233-1240.
4. Breton H., Cociglio M., Bressolle F., Peyriere H., Blayac J.P., Hillaire-Buys D. Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2005, 828:80-90.
5. Budakova L., Brozmanova H., Grundmann M., Fischer J. Simultaneous determination of antiepileptic drugs and their two active metabolites by HPLC. J. Sep. Sci. 2008, 31:1-8.
6. Burke J.T., Thenot J.P. Determination of antiepileptic drugs. J. Chromatogr. 1985, 340:199-241.
7. Chelberg R.D., Gunawan S., Treiman D.M. Simultaneous high-performance liquid-chromatographic determination of carbamazepine and its principal metabolites in human plasma and urine. Ther. Drug Monit. 1988, 10:188-193.
8. Chen K., Bashi H.K. Comparative analysis of antiepileptic drugs by gas chromatography using capillary or packed columns and by fluorescence polarization immunoassay. J. Anal. Toxicol. 1991, 15(2):82-85.
9. Dasgupta A., Vega A.E., Wells A., Datta P. Effect of heating human sera at a temperature necessary to deactivate human immunodeficiency virus on measurement of free phenytoin, free valproic acid, and free carbamazepine concentrations. Ther. Drug Monit. 1999, 21:421-425.
10. Duche P., Loiseau B. Antiepileptic Drugs 1995, 555. Raven, New York. fourth ed. R.H. Levy, R.H. Mattson, B.S. Meldrum, J.K. Penry, F.E. Dreyfuss (Eds.).
11. Elizabeth G.-S., Darla R.L., Mohamed A.V., Matthew D.K. Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography. Biomed. Chromatogr. 2007, 21(3):225-228.
12. Escandar G.M., González Gómez D., Espinosa Mansilla A., Muñoz de la Peña A., Goicoechea H.C. Determination of carbamazepine in serum and pharmaceutical preparations using immobilization on a nylon support and fluorescent detection. Anal. Chim. Acta 2004, 506:161-170.
13. Franceschi L., Furlanut M. A simple method to monitor plasma concentration of oxcarbamazepine, carbamazepine, their main metabolites and lamotrignine in epileptic patients. Pharmacol. Res. 2005, 51:297-302.
14. Goodman A.G., Hardman J.G., Limbrid L.E. Goodman and Gilman's the Pharmacological Basis of Therapeutics 2001, McGraw Hill, New York. 10th ed.
15. Hartley R., Lucock M., Cookman J.R., Becker M., Forsythe W.I. High-performance liquid-chromatographic determination of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva following solidphase sample extraction. J. Chromatogr. 1986, 380:347-356.
16. He J., Shibukawa A., Nakagawa T. Direct injection analysis of carbamazepine and its active 10,11-epoxide metabolite in plasma by use of a semipermeable surface (SPS) silica column in LC. J. Pharm. Biomed. Anal. 1992, 10(4):289-294.
17. Hemenway J.N., Jarho P., Henri J.T., Nair S.K., Velde D.V., Georg G.I., Stella V.J. Preparation and physicochemical characterization of a novel water-soluble prodrug of carbamazepine. J. Pharm. Sci. 2010, 99(4):1810-1825.
18. Huang C., He Q., Chen H. Flow injection photochemical spectrofluorimetry for the determination of carbamazepine in pharmaceutical preparations. J. Pharm. Biomed. Anal. 2002, 30(1):59-65.
19. ICH Guideline Q2 (R1), 2005. Validation of Analytical Procedures: Text and Methodology.
20. Juergens U. Routine determination of eight common anti-epileptic drugs and metabolites by high-performance liquid chromatography using a column-switching system for direct injection of serum samples. J. Chromatogr. 1984, 310:97-106.
21. Lancas F.M., Sozza M.A., Queiroz M.E.C. Simultaneous plasma lamotrignine analysis with carbamazepine, carbamazepine-10,11-epoxide, primidone, phenytoin, phenobarbital, and PEMA by micellar electrokinetic capillary chromatography (MECC). J. Anal. Toxicol. 2003, 27:304-308.
22. Lee S.H., Li M., Suh J.K. Determination of carbamazepine by chemiluminescence detection using chemically prepared tris(2,2V-bipyridine)ruthenium(III) as oxidant. Anal. Sci. 2003, 19:903-906.
23. Liu H., Delgado M., Forman L.J., Eggers C.M., Montoya J.L. Simultaneous determination of carbamazepine, phenytoin, phenobarbital, primidone and their principal metabolites by high-performance liquid chromatography with photodiode-array detection. J. Chromatogr. 1993, 616:105-115.
24. Mennickent S., Fierro R., Vega M., de Diego M., Godoy C.G. Instrumental planar chromatographic method for determination of carbamazepine in human serum. J. Sep. Sci. 2009, 32(9):1454-1458.
25. Miao X.-S., Metcalfe C.D. Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography-electrospray tandem mass spectrometry. Anal. Chem. 2003, 75:3731-3738.
26. Oh E.K., Ban E., Woo J.S., Kim C.-K. Analysis of carbamazepine and its active metabolite, carbamazepine-10,11-epoxide, in human plasma using high-performance liquid chromatography. Anal. Bioanal. Chem. 2006, 386:1931-1936.
27. Owen A., Tettey J.N., Morgan P., Pirmonhamed M., Park B.K. LC determination of carbamazepine in murine brain. J. Pharm. Biomed. Anal. 2001, 26(4):573-577.
28. Patel R.B., Patel M.R., Bhatt K.K., Patel B.G. Development and validation of HPTLC method for estimation of carbamazepine in formulations and its in vitro release study. Chromatogr. Res. Int. 2011, 8pp.
29. Queiroz R.H.C., Bertucci C., Malfará W.R., Dreossi S.A.C., Chaves A.R., Valério D.A.R., Queiroz M.E.C. Quantification of carbamazepine, carbamazepine-10,11-epoxide, phenytoin and phenobarbital in plasma samples by stir bar-sorptive extraction and liquid chromatography. J. Pharm. Biomed. Anal. 2008, 48:428-434.
30. Raggi M.A., Casamenti G., Mandrioli R., Sabbioni C., Volterra V. A rapid LC method for the identification and determination of CNS drugs in pharmaceutical formulations. J. Pharm. Biomed. Anal. 2000, 23:161-167.
31. Rezaei Z., Hemmateenejad B., Khabnadideh S., Gorgin M. Simultaneous spectrophotometric determination of carbamazepine and phenytoin in serum by PLS regression and comparison Ruth HPLC. Talanta 2005, 65:21-28.
32. Rouan M.C., Campestrini J., Le Clanche V., Lecaillon J.B., Godbillon J. Automated microanalysis of carbamazepine and its epoxide and trans-diol metabolites in plasma by column liquid chromatography. J. Chromatogr. 1992, 573(1):65-68.
33. Sanchez A., Garcia R., Abadin J.A., Duran J.A. Determination of free serum carbamazepine by protein precipitation with sulfosalicylic acid. Pharm. Pharmacol. Commun. 1999, 5:435-438.
34. Srinivasa R.K., Belorkar N. Development and validation of a specific stability indicating liquid chromatographic method for carbamazepine in bulk and pharmaceutical dosage forms. J. Adv. Pharm. Res. 2010, 1:36-47.
35. Van Rooyen G.F., Badenhorst D., Swart K.J., Hundt H.K., Scanes T., Hundt A.F. Determination of carbamazepine and carbamazepine-10,11-epoxide in human plasma by tandem liquid chromatography-mass spectrometry with electrospray ionisation. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2002, 769(1):1-7.
36. Wad N.J. Simultaneous determination of eleven antiepileptic compounds in serum by high-performance liquid chromatography. J. Chromatogr. 1984, 305:127-133.
37. Yoshida T., Imai K., Motohashi S., Hamano S., Sato M. Simultaneous determination of zonisamide, carbamazepine, carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 2006, 41:1386-1390.
38. Zhu Y., Chiang H., Wulster-Radcliffe M., Hilt R., Wong P., Kissinger C.B., Kissinger P.T. Liquid chromatography/tandem mass spectrometry for the determination of carbamazepine and its main metabolite in rat plasma utilizing an automated blood sampling system. J. Pharm. Biomed. Anal. 2005, 38(1):119-125.